Medicaid, Elevance Health
Elevance Health slashes profit forecast on persistently high medical costs
Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, becoming the latest U.S. insurer to take a hit from high demand for healthcare services.
Elevance Health’s stock tumbles as profit dented by ‘unprecedented’ Medicaid challenges
We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business,” Chief Executive Gail K.
Elevance Health Latest Insurer Battered By Higher Medical Costs
Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits tumbled more than 20%.
Elevance makes a late cut to its 2024 forecast after seeing trouble in Medicaid
Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its third quarter.
Elevance Shares Dive After Insurer Faces ‘Unprecedented’ Medicaid Challenge
It was the latest sign of how medical expenses are squeezing insurers’ earnings, a result likely to punish shares across the sector.
Medicaid drags Elevance Health as it misses on profit in Q3
Elevance Health fell short of Wall Street analysts' predictions, posting $1 billion in profit amid rising medical costs. | Elevance Health fell short of Wall Street analysts' predictions, posting $1 billion in profit amid rising medical costs.
Elevance Health's Q3 Earnings: Profit Falls Short Of Expectations On Higher Medical Costs, Issues Soft Annual Outlook
Elevance Health reported Q3 revenue of $44.7 billion, driven by higher premium yields and CarelonRx growth. However, profit fell 21%, and adjusted EPS missed expectations.
Elevance Warns on Medicaid Challenges, Hammering Health-Insurance Stocks
Elevance Health's quarterly earnings fell below expectations, the latest sign of how medical expenses are squeezing the industry. Insurance stocks sold off in morning trading. Dig deeper:
Elevance Health slashes profit forecast on persistently high costs
By Bhanvi Satija and Sneha S K (Reuters) -Elevance Health slashed its full-year profit forecast on Thursday, hurt by increased medical costs in its government-backed plans, becoming the latest health insurer to feel the pinch of persistently high demand for healthcare services.
Elevance Health stock slides after outlook cut amid rising medical expenses
Elevance Health (ELV) shares fall 12% as full-year earnings forecast is lowered due to high medical expenses, impacting the managed care industry.
Elevance Health (ELV) Q3 2024 Earnings Call Transcript
Elevance Health (NYSE: ELV) Q3 2024 Earnings Call Oct 17, 2024, 8:30 a.m. ET ...
Elevance Tumbles On Forecast Cut, Third-Quarter Earnings Miss
Elevance Health Inc. shares sank in early trading after the insurer cut its outlook for the year and reported third-quarter ...
Modern Healthcare4h
Elevance shares plummet as its Medicaid business struggles
The results show a worsening outlook for health insurers that for years have relied on government programs for growth.
Elevance Health: Q3 Earnings Snapshot
The health insurer posted revenue of $45.11 billion in the period. Its adjusted revenue was $44.72 billion, beating Street ...
UnitedHealth forecasts 2025 profit below Street estimates, shares fall
UnitedHealth Group provided a 2025 profit forecast below Wall Street estimates on Tuesday as it expects pressure across its ...
LVW Advisors LLC Sells 303 Shares of Elevance Health, Inc. (NYSE:ELV)
LVW Advisors LLC decreased its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 37.3% during the 3rd quarter, ...
Inside Business 2024 Top Forty Under 40: Denzel Brock, Elevance Health
With Elevance Health for Good, Brock teams up with organizations that promote health and wellness in the 757. He’s also part of West Indies United, working to keep West Indian and Caribbean ...
Elevance: Our Top Value Pick Trading At 12.5x Earnings And Growing At 12.5%
Elevance is a high-quality stock with consistent EPS growth, trading at a significant discount to peers like UnitedHealth.